Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.48 USD | -7.20% | +13.33% | +11.64% |
May. 17 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
May. 17 | Deutsche Bank Adjusts GoodRx Price Target to $9 From $8, Maintains Hold Rating | MT |
Business Summary
Number of employees: 694
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Prescription Transactions
73.4
%
| 551 | 71.8 % | 551 | 73.4 % | +0.04% |
Subscription
12.6
%
| 96 | 12.5 % | 94 | 12.6 % | -1.83% |
Pharma Manufacturer Solutions
11.3
%
| 99 | 13.0 % | 85 | 11.3 % | -14.44% |
Other
2.7
%
| 20 | 2.7 % | 20 | 2.7 % | -1.83% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 767 | 100.0 % | 750 | 100.0 % | -2.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Scott Wagner
CEO | Chief Executive Officer | 53 | 23-04-24 |
Trevor Bezdek
FOU | Founder | 46 | 11-08-31 |
Douglas Hirsch
FOU | Founder | 53 | 11-08-31 |
Karsten Voermann
DFI | Director of Finance/CFO | 55 | 20-02-29 |
Whitney Notaro
IRC | Investor Relations Contact | - | 20-09-30 |
Aaron Crittenden
PRN | Corporate Officer/Principal | - | - |
Gracye Cheng
LAW | General Counsel | - | 13-12-31 |
Romin Nabiey
AUD | Comptroller/Controller/Auditor | 37 | 17-04-30 |
Andrew Slutsky
SAM | Sales & Marketing | 38 | 19-09-30 |
Scott Paul
PRN | Corporate Officer/Principal | - | 22-05-08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Agnes Rey-Giraud
BRD | Director/Board Member | 59 | 16-05-31 |
Dipanjan Deb
BRD | Director/Board Member | 54 | 15-09-30 |
Greg Mondre
BRD | Director/Board Member | 49 | 18-09-30 |
Kelly Kennedy
BRD | Director/Board Member | 55 | Dec. 21 |
Julie Bradley
BRD | Director/Board Member | 55 | 20-07-31 |
Douglas Hirsch
FOU | Founder | 53 | 11-08-31 |
Trevor Bezdek
FOU | Founder | 46 | 11-08-31 |
Director/Board Member | 44 | 15-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 280,869,320 | 0 | 0 | 21.12 % |
Stock B | 1 | 94,335,792 | 79,255,576 ( 84.01 %) | 0 |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.64% | 3.02B | |
+34.54% | 472B | |
+6.66% | 138B | |
+32.61% | 98.36B | |
+6.99% | 93.44B | |
+61.15% | 59.13B | |
+18.75% | 47.5B | |
+24.94% | 39.41B | |
+0.13% | 35.99B | |
+15.50% | 29.22B |
- Stock Market
- Equities
- GDRX Stock
- Company GoodRx Holdings, Inc.